Singapore markets closed

Biodesix, Inc. (BDSX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.2350-0.0250 (-1.98%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
49,087
49,087
38,212
54,506
45,557
Cost of revenue
13,010
13,010
14,154
30,518
21,998
Gross profit
36,077
36,077
24,058
23,988
23,559
Operating expenses
Research development
9,988
9,988
13,102
12,789
10,818
Selling general and administrative
67,387
67,387
61,462
50,517
34,857
Total operating expenses
77,375
77,375
74,564
63,306
45,675
Operating income or loss
-41,298
-41,298
-50,506
-39,318
-22,116
Interest expense
9,536
9,536
8,072
4,508
7,604
Total other income/expenses net
-1,312
-1,312
-6,869
667
-1,630
Income before tax
-52,146
-52,146
-65,447
-43,159
-31,350
Income from continuing operations
-52,146
-52,146
-65,447
-43,159
-31,350
Net income
-52,146
-52,146
-65,447
-43,159
-31,350
Net income available to common shareholders
-52,146
-52,146
-65,447
-43,159
-31,350
Basic EPS
-1.55
-
-1.55
-1.58
-6.48
Diluted EPS
-1.55
-
-1.55
-1.58
-6.48
Basic average shares
42,103
-
42,103
27,365
4,838
Diluted average shares
42,103
-
42,103
27,365
4,838